findmyKOL

Ruwani Gunawardane, MD

Basic profile

University of Maryland, Baltimore

ORCIDNone on fileNPI
RegionFulton, MD · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2004Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ruwani Gunawardane is a Neurology physician affiliated with University of Maryland, Baltimore. OpenAlex indexes 7 publications with 344 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

344citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
80companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

7625 Maple Lawn Blvd
Suite 100
Fulton, MD 207592565

Telephone

301-490-6085

Registry record last updated 8 Nov 2011.

View the NPPES registry record

Industry payments

80 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    70.9%
    Neuromuscular Blocker70.6%
    Onabotulinumtoxina100%Botox0%
    Part D + Part B<11 patients
    gamma-Aminobutyric Acid-ergic Agonist0.2%
    Baclofen100%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    22.7%
    N-methyl-D-aspartate Receptor Antagonist5.4%
    Memantine Hcl100%
    Part D208 patients
    Cholinesterase Inhibitor2.8%
    Donepezil Hcl53%Rivastigmine47%
    Part D<11 patients

    + 18 more classes in this area

  • Cardiovascular

    4.4%
    Statin2.9%
    Atorvastatin Calcium87%Rosuvastatin Calcium13%
    Part D114 patients
    Beta blocker0.6%
    Propranolol Hcl71%Propranolol Hcl Er29%
    Part D<11 patients

    + 5 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”